Bill Hoffman
InvestorVenture Partner at Vensana Capital · Board director at VI1 · Executive at Inari Medical
San Francisco, California, United States
About
Bill Hoffman, a serial medical-device CEO who led Inari Medical to IPO and guided Visualase into Medtronic acquisition, now chairs interventional and cardiovascular boards and builds clinical/commercial playbooks.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices
Board director at VI1
Intro paths
→
In turn, Bill can intro founders to VI1's investors below.
VI1's investors · 1
Executive at Inari Medical
Intro paths
→
In turn, Bill can intro founders to Inari Medical's investors below.
Experience
- Osanni BioChief Executive Officercurrent2022 — presentSan Francisco Bay Area
- Stanford UniversityDirector, Biotechnology - Stanford Byers Center for Biodesigncurrent2022 — present
- Stanford UniversityAdjunct Professor - Department of Bioengineeringcurrent2023 — present
- Stanford UniversityCo-Instructor, Biodesign Innovation Course2017 — 2022Palo Alto, CA
- Presidio Medical, Inc.Board Membercurrent2017 — present
- Presidio Medical, Inc.Chief Executive Officer2017 — 2021
- Vensana CapitalAdvisory Board Membercurrent2019 — present
- Tarsus Pharmaceuticals, Inc.Chairman2017 — 2022
- Oyster Point Pharma, Inc.Chairman2017 — 2020
- AllerganVice President, Neurostimulation2015 — 2017South San Francisco, California, USA
- Oculeve, Inc.Chief Executive Officer2012 — 2015South San Francisco, CA, USA
- Stanford UniversityVision Research Fellow2011 — 2012
- Stanford UniversityBiodesign Fellow2010 — 2011Stanford, CA
- Case Western Reserve UniversityPostdoctoral Scholar2010
- Case Western Reserve UniversityGraduate Student2004 — 2009
- Boston ScientificIntern, R&D Systems & Technology2009
Skills & more
Medical Devices68Biomedical Engineering77Biotechnology29Life Sciences21Clinical Research62Clinical Development25Cross-functional Team Leadership6Strategy18Healthcare6Clinical Trials7Biomaterials6Biomechanics5
+12 more
Business DevelopmentCommercializationElectrophysiologyFDALifesciencesMedicineMolecular BiologyNeuroscienceProduct DevelopmentR&DResearchStart-upsFrom Bill's professional profile.
Deals · 1
Monteris MedicalBoard seat
via Vensana Capital · filed Mar 2019 · $12.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Vensana Capital
Allison King
Investment Professional at Vensana Capital
Amrinder Singh
Partner at Vensana Capital
Greg Banker
Partner at Vensana Capital
Justin Klein
Co-Founder and Managing Partner at Vensana Capital
Kevin Hykes
Venture Partner at Vensana Capital
Kirk Nielsen
Co-Founder and Managing Partner at Vensana Capital
Maria Berkman
Partner at Vensana Capital
Mike Kramer
Partner at Vensana Capital
Frequently asked questions
- Who is Bill Hoffman?
- Bill Hoffman, a serial medical-device CEO who led Inari Medical to IPO and guided Visualase into Medtronic acquisition, now chairs interventional and cardiovascular boards and builds clinical/commercial playbooks.
- Where does Bill Hoffman work?
- Bill Hoffman is Venture Partner at Vensana Capital and Board director at VI1 and Executive at Inari Medical.
- What does Bill Hoffman invest in?
- Bill Hoffman invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
- What boards does Bill Hoffman sit on?
- Bill Hoffman holds tracked board seats at Monteris Medical.
- Where did Bill Hoffman go to school?
- Bill Hoffman studied at Stanford University (Research Fellow, Ophthalmology); Stanford University (Biodesign Fellowship); Case Western Reserve University (Ph.D., Biomedical Engineering/Neuroengineering).
Same school
Also attended Stanford University2,000
Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital
+ 1,994 more
Also attended Case Western Reserve University54
Will BruneSenior Associate at Mutual Capital PartnersKT MooreAdvisor at Clear VenturesPete KoomenGeneral Partner at Y CombinatorAsheem ChandnaPartner at Greylock focused on enterprise, cybersecurity, and infrastructure softwareMatt SteinChief Information Officer at Flare Capital PartnersKaren SpilizewskiBiomedical engineer helping accelerate life science technologies from development into the marketplace
+ 48 more
Also attended Vanderbilt University196
Jacob JofeInvestor at Index VenturesRoss Perot Jr.Chairman of The Perot Group at Perot JainDavid JohnsonManaging Director at Intel Capital, North AmericaTom DriscollPrincipal at Differential VenturesSabina SmithPrincipal at Scale Venture PartnersPayton DobbsOperating Partner at Hoxton Ventures
+ 190 more
Shared employers
Also worked at Stanford University722
Ann Miura-KoCo-founding Partner at FloodgateBalaji SrinivasanAngel investor and founder of The Network SchoolMartin CasadoGeneral Partner at Andreessen HorowitzMike KriegerCo-founder of Instagram; Chief Product Officer at AnthropicAndy FangCo-founder & CTO of DoorDashRyan SheaCo-founder of Blockstack (Stacks)
+ 716 more
Also worked at Presidio Medical, Inc.1
Also worked at Tarsus Pharmaceuticals, Inc.1
Also worked at Case Western Reserve University12
Will BruneSenior Associate at Mutual Capital PartnersAkhil SaklechaAdvisor - Healthtech at Augment VenturesAarti ChandnaSV2 Board Member at Silicon ValleyDanielle MorrisSenior Director, Revenue & Compliance Management at JumpStart VenturesCarmen FontanaInvestor at Countdown CapitalDavid MoonPrincipal at Cultivation Capital
+ 6 more